Security · CUSIP 803607AD2
SAREPTA THERAPEUTICS INC
NOTE 1.250% 9/1 · institutional ownership from 13F filings
13F holders
5
Shares held
1.6M
Value held
$1.6M
New / sold out
1 / 2
Added / reduced
2 / 0
net -3.5M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| FINANCIAL CONSULATE, INC | 1,047,000 | $990.9K | 0.11% |
| HB Wealth Management, LLC | 555,000 | $523.2K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 26,000 | $24.0K | 0.00% |
| Greenspring Advisors, LLC | 14,000 | $13.3K | 0.00% |
| ROTHSCHILD INVESTMENT LLC | 1,000 | $943 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| FINANCIAL CONSULATE, INC | Added | +48,000 | +4.8% |
| Greenspring Advisors, LLC | New | +14,000 | – |
| Cambridge Investment Research Advisors, Inc. | Added | +13,000 | +100.0% |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Sold out | -3,500,000 | -100.0% |
| Wealthspire Advisors, LLC | Sold out | -27,000 | -100.0% |